We've released the new Subject Search, designed to be simpler and faster than the application below.
PC3301 - Integrated Therapeutics 2
Credit points: |
6 |
Year: |
2021 |
Student Contribution Band: |
Band
2 |
Administered by: |
College of Medicine & Dentistry |
Cardiovascular, renal, endocrine and gastrointestinal disease are major causes of
morbidity and mortality in the Australian population. Multiple factors contribute
to a person's overall cardiovascular risk including nutrition, metabolism and other
medical conditions such as hypertension, dyslipidaemia, renal disease and diabetes.
Lifestyle factors such as physical inactivity, obesity and smoking also play a role.
Diabetes is a particularly important disease amongst this group, as it can lead to
the failure of multiple organ systems, and has been increasing in Australia, particularly
amongst Indigenous Australians and Torres Strait Islanders. This subject also introduces
common conditions that affect the gastrointestinal and hepatobiliary systems and will
describe the pathophysiology of these conditions and their clinical management. The
subject will also explore the principles of nutrition in adults and children including
the supply of supplementary feeding such as enteral nutrition (EN) or total parenteral
nutrition (TPN). Students will demonstrate an understanding of the complex pathophysiological
origins of these diseases and how these diseases inter-relate and affect each other
to develop foundational competence in the management of patients with multiple co-morbidities
relating to these systems
Learning Outcomes
- Describe the pathophysiology and clinical presentation of common cardiovascular, metabolic,
renal, gastrointestinal and hepatobiliary diseases relevant to pharmacy practice;
- Effectively apply relevant clinical guidelines to the management of patients with
cardiovascular, renal, endocrine (diabetes) and gastrointestinal disease;
- Develop, propose and evaluate pharmacological treatment plans for patients with common
cardiovascular, metabolic, renal, gastrointestinal and hepatobiliary diseases;
- Demonstrate appropriate screening, communication and clinical skills necessary for
the prevention, identification, and management of these conditions including non-drug
and dietary interventions;
- Explain the relationship between the pharmacology of drugs used to manage diseases
in this subject and the pathophysiology of those diseases.
Subject Assessment
- Written > Test/Quiz 1 - (10%) - Individual
- Oral > Presentation 1 - (20%) - Individual
- Written > Case report 1 - (40%) - Individual
- Performance/Practice/Product > Objective structured clinical examination (OSCE) - (20%) - Individual
- Written > Test/Quiz 2 - (10%) - Individual.
Assumed Knowledge:
|
Students will be expected to have completed all core level 1 and 2 subjects. |
Availabilities
|
Townsville,
Study Period 1,
Internal
|
Census Date 25-Mar-2021 |
Coordinator: |
Assoc. Professor John Smithson |
Lecturers:
|
Ms Kathy Thomas, Professor Beverley Glass, Dr Margaret Jordan, Assoc. Professor Peta-Ann Teague, Assoc. Professor John Smithson, Mr Shane MacDonald, Mrs Amanda Mackay, Ms Cassie Lanskey, Dr Robi Islam. |
Workload expectations: |
The student workload for this
6
credit point subject is approximately
260 hours.
- 12 hours lectures (didactic or interactive)
- 48 hours - Guided Learning Sessions
- 60 hours pre-recorded content/lectures
- assessment and self-directed study
|
|
|
Note:
Minor variations might occur due to the continuous Subject quality improvement process,
and in case
of minor variation(s) in assessment details, the Subject Outline represents the latest
official information.